References

1. 1. Rubio-Tapia A., Hill I.D., Semrad C. et al. American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease // Am. J. Gastroenterol. 2023. Jan. 1;118(1):59–76. DOI: 10.14309/ajg.0000000000002075
2. 2. Husby S., Koletzko S., Korponay-Szabó I. et al. European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020 // J. Pediatr. Gastroenterol. Nutr. 2020. Jan;70(1):141–156. DOI: 10.1097/MPG.0000000000002497. PMID: 31568151
3. 3. Therrien A., Kelly C.P., Silvester J.A. Celiac Disease: Extra intestinal Manifestations and Associated Conditions // J Clin Gastroenterol. 2020, vol. 54, no. 1, pp. 8–21. DOI: 10.1097/MCG.0000000000001267
4. 4. Парфёнов А.И., Быкова С.В., Сабельникова Е.А. и др. Всероссийский консенсус по диагностике и лечению целиакии у детей и взрослых // Терапевтический архив. 2017. № 89(3). С. 94–107.
5. 5. Talarico V., Giancotti L, Mazza G.A. et al. Iron Deficiency Anemia in Celiac Disease // Nutrients. 2021, May, 17;13(5):1695. DOI: 10.3390/nu13051695
6. 6. Montoro-Huguet M.A., Santolaria-Piedrafita S., Cañamares-Orbis P., García-Erce J.A. Iron Deficiency in Celiac Disease: Prevalence, Health Impact, and Clinical Management // Nutrients. 2021, Sep., 28;13(10):3437. DOI: 10.3390/nu13103437
7. 7. Mahadev S., Laszkowska M., Sundström J. et al. Prevalence of Celiac Disease in Patients With Iron Deficiency Anemia-A Systematic Review With Meta-analysis // Gastroenterology, 2018, Aug.,155(2):374-382.e1. DOI: 10.1053/j.gastro.2018.04.016
8. 8. Kochhar R., Jain K., Thapa B.R. et al. Clinical presentation of celiac disease among pediatric compared to adolescent and adult patients // Indian J. Gastroenterol. 2012, 31:116–120. DOI: 10.1007/s12664-012-0198-9
9. 9. Bottaro G., Cataldo F., Rotolo N. et al. The clinical pattern of subclinical/silent celiac disease: Analyses is on 1026 consecutive cases // Am. J. Gastroenterol. 1999, 94:691–696. DOI: 10.1016/S0002-9270(98)00819-3
10. 10. Smukalla S., Lebwohl B., Mears J.G. et al. How Often Do Hematologists Consider Celiac Disease in Iron-Deficiency Anemia? Results of a National Survey // Clin. Adv. Hematol. Oncol. 2014, 12:100–105.
11. 11. Chin R.L., Latov N., Green P.H. et al. Neurologic complications of celiac disease // J. Clin. Neuromuscul Dis. 2004, vol. 5, no. 3, pp. 129–137. PMID: 19078744.
12. 12. Hadjivassiliou M., Croall I.D., Zis P. et al. Neurologic Deficits in Patients With Newly Diagnosed Celiac Disease Are Frequent and Linked With Autoantibodies to Transglutaminase 6 // Clin. Gastroenterol. Hepatol. 2019, vol. 17, no. 13, pp. 2678–2686. DOI: 10.1016/j.cgh.2019.03.014
13. 13. Thawani S.P., Brannagan T.H. 3rd, Lebwohl B. et al. Risk of Neuropathy Among 28,232 Patients With Biopsy-Verified Celiac Disease // JAMA Neurol. 2015, vol. 72, no. 6, pp. 806–811. DOI: 10.1001/jamaneurol.2015.0475
14. 14. Zis P., Sarrigiannis P.G., Rao D.G. et al. Quality of Life in Patients with Gluten Neuropathy: A Case-Controlled Study // Nutrients. 2018, vol. 10, no. 10, p. 1366. DOI: 10.3390/nu10101366
15. 15. Dimitrova A.K., Ungaro R.C., Lebwohl B. et al. Prevalence of migraine in patients with celiac disease and inflammatory bowel disease // Headache. 2013, vol. 53, no. 2, pp. 344–355. DOI: 10.1111/j.1526-4610.2012.02260.x
16. 16. Lebwohl B., Roy A., Alaedini A. et al. Risk of Headache-Related Healthcare Visits in Patients with Celiac Disease: A Population-Based Observational Study // Headache. 2016, vol. 56, no. 5, pp. 849–858. DOI: 10.1111/head.12806
17. 17. Zis P., Julian T., Hadjivassiliou M. Headache Associated with Coeliac Disease: A Systematic Review and Meta-Analysis // Nutrients. 2018, vol. 10, no. 10, p. 1445. DOI: 10.3390/nu10101445
18. 18. Jericho H., Sansotta N., Guandalini S. Extraintestinal Manifestations of Celiac Disease: Effectiveness of the Gluten-Free Diet // J. Pediatr. Gastroenterol. Nutr. 2017, vol. 65, no. 1, pp. 75–79. DOI: 10.1097/MPG.0000000000001420
19. 19. Lichtwark I.T., Newnham E.D., Robinson S.R. et al. Cognitive impairment in coeliac disease improves on a gluten-free diet and correlates with histological and serological indices of disease severity // Aliment Pharmacol. Ther. 2014, vol. 40, no. 2, pp. 160–170. DOI: 10.1111/apt.12809
20. 20. Yelland G.W. Gluten-induced cognitive impairment (“brain fog”) in coeliac disease // J. Gastroenterol. Hepatol. 2017, vol. 32, suppl. 1, pp. 90–93. DOI: 10.1111/jgh.13706
21. 21. Aljulifi M.Z., Mahzari M., Alkhalifa L. et al. The prevalence of celiac disease in Saudi patients with type 1 diabetes mellitus // Ann. Saudi Med. 2021, Mar–Apr, 41(2):71–77. DOI: 10.5144/0256-4947.2021.71
22. 22. Eland I., Klieverik L., Mansour A.A., Al-Toma A. Gluten-Free Diet in Co-Existent Celiac Disease and Type 1 Diabetes Mellitus: Is It Detrimental or Beneficial to Glycemic Control, Vascular Complications, and Quality of Life? // Nutrients. 2022, Dec. 30;15(1):199. DOI: 10.3390/nu15010199
23. 23. Tersigni C., Castellani R., de Waure C. et al. Celiac disease and reproductive disorders: meta-analysis of epidemiologic associations and potential pathogenic mechanisms // Hum. Reprod. Update. 2014, Jul.–Aug.; 20(4):582-93. DOI: 10.1093/humupd/dmu007
24. 24. Быкова С.В., Сабельникова Е.А., Парфёнов А.И. и др. Reproductive disorders in women with celiac disease. Effect of the etiotropic therapy // Экспериментальная и клиническая гастроэнтерология. 2011. № 3. С. 12–8.
25. 25. Silvester J.A., Graff L.A., Rigaux L. et al. Symptomatic suspected gluten exposure is common among patients with coeliac disease on a gluten-free diet // Aliment Pharmacol Ther., 2016; 44:612.
26. 26. Graziano M., Rossi M. An update on the cutaneous manifestations of coeliac disease and non-coeliac gluten sensitivity // Int. Rev. Immunol. 2018:1–10.
27. 27. Lungaro L., Manza F., Costanzini A. et al. Osteoporosis and Celiac Disease: Updates and Hidden Pitfalls // Nutrients. 2023, vol. 15, no. 5, p. 1089. DOI: 10.3390/nu15051089
28. 28. Абдулова Е.А., Дроздов В.Н., Парфёнов А.И. Минеральная плотность костной ткани у больных целиакией и медикаментозная коррекция её нарушений // Экспериментальная и клиническая гастроэнтерология. 2011. № 3. С. 78–83.
29. 29. Stenson W.F., Newberry R., Lorenz R. et al. Increased Prevalence of Celiac Disease and Need for Routine Screening Among Patients With Osteoporosis // Arch. Intern. Med. 2005; 165:393–399. DOI: 10.1001/archinte.165.4.393
30. 30. Hoffmanova I., Sanchez D., Tuckova L. et al. Celiac Disease and Liver Disorders: From Putative Pathogenesis to Clinical Implications // Nutrients. 2018, vol. 10, no. 7, p. 892. DOI: 10.3390/nu10070892
31. 31. Pelaez-Luna M., Schmulson M., Robles-Diaz G. Intestinal involvement is not sufficient to explain hypertransaminasemia in celiac disease? // Med. Hypotheses. 2005, vol. 65, no. 5, pp. 937–941. DOI: 10.1016/j.mehy.2005.05.016
32. 32. Rubio-Tapia A., Murray J.A. The Liver and Celiac Disease // Clin. Liver Dis. 2019, vol. 23, no. 2, pp. 167–176. DOI: 10.1016/j.cld.2018.12.001
33. 33. Первичный склерозирующий холангит. Взгляд терапевта и хирурга / Под ред. И.Е. Хатькова, Е.В. Винницкой. М.: Литтерра, 2019.
34. 34. Boberg K.M., Spurkland A., Rocca G. et al. The HLA- DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis // Scand. J. Gastroenterol. 2001, vol. 36, no. 8, pp. 886–890. DOI: 10.1080/003655201750313441
35. 35. Murray J.A., Moore S.B., Van Dyke C.T. et al. HLA DQ gene dosage and risk and severity of celiac disease // Clin. Gastroenterol. Hepatol. 2007, vol. 5, no. 12, pp. 1406–1412. DOI: 10.1016/j.cgh.2007.08.013